Model-based Drug Development-Reference-Cited by-同舟云学术

Model-based Drug Development

Published:2007-05-23 Issue:1 Volume:82 Page:21-32
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Lalonde R L,Kowalski K G,Hutmacher M M,Ewy W,Nichols D J,Milligan P A,Corrigan B W,Lockwood P A,Marshall S A,Benincosa L J,Tensfeldt T G,Parivar K,Amantea M,Glue P,Koide H,Miller R

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. Can the pharmaceutical industry reduce attrition rates?

2. Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development

3. Learning versus confirming in clinical drug development*

4. Role of Mechanistically-Based Pharmacokinetic/Pharmacodynamic Models in Drug Development

Cited by 375 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Virtual Drug Study to New Drug Research and Development: Challenges and Opportunity;Clinical Pharmacokinetics;2024-09-03

2. Driving Efficiency: Leveraging Model‐Informed Approaches in 505(b)(2) Regulatory Actions;The Journal of Clinical Pharmacology;2024-08-09

3. Bioprinting of hepatic tissue using 3D technology: Transitioning beyond laboratory models to real-world applications in medical treatments;Applied Materials Today;2024-08

4. Application of Model-informed Drug Development (MIDD) in Regulatory Submissions for Drug Approval in Japan;2024-07-18

5. Disease progression modeling with temporal realignment: An emerging approach to deepen knowledge on chronic diseases;Pharmacology & Therapeutics;2024-07